Woodcock: Use Of Real-World Evidence Still Brings ‘A Lot Of Problems’

  
CDER Dir. Janet Woodcock at Reagan-Udall Foundation for FDA.(2)
Janet Woodcock, now FDA acting commissioner, at a Reagan-Udall Foundation for the FDA event in 2019 • Source: Ferdous Al-Faruque

More from Regulation

More from Policy & Regulation